These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15237089)

  • 1. Myeloperoxidase and plaque vulnerability.
    Hazen SL
    Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1143-6. PubMed ID: 15237089
    [No Abstract]   [Full Text] [Related]  

  • 2. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.
    Daugherty A; Dunn JL; Rateri DL; Heinecke JW
    J Clin Invest; 1994 Jul; 94(1):437-44. PubMed ID: 8040285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of atherosclerotic plaque development and rupture: an overview.
    Rohde LE; Lee RT
    Semin Vasc Med; 2003 Nov; 3(4):347-54. PubMed ID: 15199441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atherothrombosis: role of tissue factor; link between diabetes, obesity and inflammation.
    Meerarani P; Moreno PR; Cimmino G; Badimon JJ
    Indian J Exp Biol; 2007 Jan; 45(1):103-10. PubMed ID: 17249334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunopathogenesis of atherosclerosis: the Mainz hypothesis].
    Bhakdi S
    Dtsch Med Wochenschr; 2002 Feb; 127(8):390-4. PubMed ID: 11859449
    [No Abstract]   [Full Text] [Related]  

  • 6. Atherothrombotic disorders: new insights from hematology.
    Andreotti F; Becker RC
    Circulation; 2005 Apr; 111(14):1855-63. PubMed ID: 15824214
    [No Abstract]   [Full Text] [Related]  

  • 7. Insights into the molecular mechanisms of plaque rupture and thrombosis.
    Shah PK
    Indian Heart J; 2005; 57(1):21-30. PubMed ID: 15852890
    [No Abstract]   [Full Text] [Related]  

  • 8. Supplementary taurine may stabilize atheromatous plaque by antagonizing the activation of metalloproteinases by hypochlorous acid.
    McCarty MF
    Med Hypotheses; 2004; 63(3):414-8. PubMed ID: 15288359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Mikamo Lecture 2002. Therapeutic targets for the treatment of atherothrombosis in the new millennium--clinical frontiers in atherosclerosis research.
    Fuster V; Corti R; Badimon JJ
    Circ J; 2002 Sep; 66(9):783-90. PubMed ID: 12224812
    [No Abstract]   [Full Text] [Related]  

  • 10. Inflammation and neovascularization in diabetic atherosclerosis.
    Purushothaman KR; Meerarani P; Moreno PR
    Indian J Exp Biol; 2007 Jan; 45(1):93-102. PubMed ID: 17249333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of asymptomatic coronary thrombosis and plaque disruption: comparison of non-cardiac and cardiac deaths among autopsy cases.
    Sato Y; Hatakeyama K; Marutsuka K; Asada Y
    Thromb Res; 2009 May; 124(1):19-23. PubMed ID: 19000633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleiotropic roles of S100A12 in coronary atherosclerotic plaque formation and rupture.
    Goyette J; Yan WX; Yamen E; Chung YM; Lim SY; Hsu K; Rahimi F; Di Girolamo N; Song C; Jessup W; Kockx M; Bobryshev YV; Freedman SB; Geczy CL
    J Immunol; 2009 Jul; 183(1):593-603. PubMed ID: 19542470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloperoxidase and its contributory role in inflammatory vascular disease.
    Lau D; Baldus S
    Pharmacol Ther; 2006 Jul; 111(1):16-26. PubMed ID: 16476484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From vulnerable plaque to atherothrombosis.
    Thim T; Hagensen MK; Bentzon JF; Falk E
    J Intern Med; 2008 May; 263(5):506-16. PubMed ID: 18410594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update of the Grützbalg hypothesis: the role of thrombosis and coagulation in atherosclerotic progression.
    Yee KO; Ikari Y; Schwartz SM
    Thromb Haemost; 2001 Feb; 85(2):207-17. PubMed ID: 11246534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can we stabilize unstable plaque?
    Paoletti R; Cignarella A
    Curr Atheroscler Rep; 2003 Nov; 5(6):423-4. PubMed ID: 14525673
    [No Abstract]   [Full Text] [Related]  

  • 17. Endothelial function: cardiac events.
    Lerman A; Zeiher AM
    Circulation; 2005 Jan; 111(3):363-8. PubMed ID: 15668353
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
    Finn AV; Joner M; Nakazawa G; Kolodgie F; Newell J; John MC; Gold HK; Virmani R
    Circulation; 2007 May; 115(18):2435-41. PubMed ID: 17438147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein.
    Maier W; Altwegg LA; Corti R; Gay S; Hersberger M; Maly FE; Sütsch G; Roffi M; Neidhart M; Eberli FR; Tanner FC; Gobbi S; von Eckardstein A; Lüscher TF
    Circulation; 2005 Mar; 111(11):1355-61. PubMed ID: 15753219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherothrombosis and high-risk plaque: part I: evolving concepts.
    Fuster V; Moreno PR; Fayad ZA; Corti R; Badimon JJ
    J Am Coll Cardiol; 2005 Sep; 46(6):937-54. PubMed ID: 16168274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.